🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · Real-Time Price · USD
61.36
-0.63 (-1.02%)
At close: Nov 19, 2026, 4:00 PM EST
60.14
-1.22 (-1.99%)
After-hours: Nov 19, 2026, 4:44 PM EST

Eton Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
49.86-4.6-3.82-0.94-9.02-1.96
Depreciation & Amortization
4.984.041.150.91.770.46
Other Amortization
0.660.71.110.120.130.15
Loss (Gain) From Sale of Assets
------0.18
Stock-Based Compensation
7.425.513.173.144.223.38
Other Operating Activities
-9.025.730.60.080.06-0.37
Change in Accounts Receivable
-13.41-6.4-3.12-1.563.62-5.42
Change in Inventory
3.13-5.88-1.84-0.37-0.010.69
Change in Accounts Payable
2.246.812.320.05-0.01-0.57
Change in Other Net Operating Assets
-10.524.611.415.394.06-0.91
Operating Cash Flow
38.3510.520.976.824.82-4.72
Operating Cash Flow Growth
79.96%986.07%-85.78%41.36%--

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.13-0.33-0.03--0.04-0.01
Sale of Property, Plant & Equipment
-----0.7
Cash Acquisitions
---30---
Sale (Purchase) of Intangibles
-18.23--9.99-0.78-2.75-3.25
Investing Cash Flow
-18.36-0.33-40.01-0.78-2.79-2.56

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
--25.31---
Long-Term Debt Repaid
---1.16-1.16-0.39-0.15
Net Debt Issued (Repaid)
-8-24.15-1.16-0.39-0.15
Issuance of Common Stock
6.510.828.440.380.250.54
Repurchase of Common Stock
----0.18--
Financing Cash Flow
-1.490.8232.59-0.96-0.130.39

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
18.5111.01-6.455.081.9-6.89

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
38.2210.190.946.824.78-4.73
Free Cash Flow Growth
81.87%980.70%-86.16%42.48%--
Free Cash Flow Margin
27.09%12.75%2.42%21.54%22.51%-21.66%
Free Cash Flow Per Share
1.220.380.040.270.19-0.19
Levered Free Cash Flow
13.9611.16-18.785.65.36-7.02
Unlevered Free Cash Flow
15.9913.45-18.646.155.83-6.52

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
3.333.330.670.840.730.82
Cash Income Tax Paid
0.110.120.080.25--
Change in Working Capital
-18.56-0.86-1.233.517.66-6.21
SEC Filings: 10-K · 10-Q